Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity.

Nicholas Mitsiades, Wei‐Hsuan Yu, V. Poulaki, +2

PubMed

Chemoprevention StrategyApoptosisImmunologyCell DeathTumor Cells +17

The Role of Advanced Glycation End Products in Retinal Microvascular Leukostasis

Tara Moore, Jonathan E. Moore, Yuichi Kaji, +8

Investigative Ophthalmology & Visual Science

VEGF_164(165)as the Pathological Isoform: Differential Leukocyte and Endothelial Responses through VEGFR1 and VEGFR2

Tomohiko Usui, Susumu Ishida, Kenji Yamashiro, +9

Investigative Ophthalmology & Visual Science

Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.

Nicholas Mitsiades, V. Poulaki, C Mitsiades, +1

PubMed

ApoptosisImmunologyPathologyCell DeathEsft Cell Lines +15

Rapid ocular angiogenic control via naked DNA delivery to cornea.

Stephen U. Stechschulte, A.M. Joussen, Horst A. von Recum, +6

PubMed

Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.

Nicholas Mitsiades, V. Poulaki, Sofia Tseleni‐Balafouta, +2

PubMed

ApoptosisImmunologyCell DeathPathologyTumor Biology +16

In vivo retinal gene expression in early diabetes.

Antonia M. Joussen, S. Huang, V. Poulaki, +4

PubMed

Stimulation of tumor growth by recombinant human insulin-like growth factor-I (IGF-I) is dependent on the dose and the level of IGF-I receptor expression.

Andrew A. Butler, Vicky A. Blakesley, V. Poulaki, +4

PubMed

ImmunologyCell ProliferationInsulin SignalingTumor BiologyTumor Latency +14

Fas-Mediated Apoptosis in Ewing's Sarcoma Cell Lines by Metalloproteinase Inhibitors

Nicholas Mitsiades, V. Poulaki, Alvaro Leone, +1

JNCI Journal of the National Cancer Institute

Inhibition of inflammatory corneal angiogenesis by TNP-470.

Antonia M. Joussen, W.-D. Beecken, Y Moromizato, +3

PubMed